Tolerability on Serious Adverse Events of First-Line Bevacizumab and Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
商品説明・詳細
送料・お届け
商品情報
Tolerability on Serious Adverse Events of First-Line Bevacizumab and Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis,The Winding Roadmap of Biomarkers Toward Clinic: Lessons from Predictors of Resistance to Anti-EGFRs in Metastatic Colorectal Cancer,HER2 expression and genOmic characterization of rESected brain metastases from colorectal cancer: the HEROES study | British Journal of Cancer,Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis | eLife,Machine learning-driven estimation of mutational burden highlights DNAH5 as a prognostic marker in colorectal cancer | Biology Direct | Full Text